Chlorine in PDB 7rmj: Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Protein crystallography data
The structure of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide, PDB code: 7rmj
was solved by
S.M.Bester,
M.Kvaratskhelia,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.29 /
2.27
|
Space group
|
P 6
|
Cell size a, b, c (Å), α, β, γ (°)
|
160.023,
160.023,
57.598,
90,
90,
120
|
R / Rfree (%)
|
21.4 /
24.8
|
Other elements in 7rmj:
The structure of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide also contains other interesting chemical elements:
Chlorine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
20;
Page 3, Binding sites: 21 -
23;
Binding sites:
The binding sites of Chlorine atom in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
(pdb code 7rmj). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 23 binding sites of Chlorine where determined in the
Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide, PDB code: 7rmj:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Chlorine binding site 1 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 1 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl301
b:76.8
occ:0.65
|
CL27
|
A:61F301
|
0.0
|
76.8
|
0.7
|
CL27
|
A:61F301
|
0.1
|
77.2
|
0.3
|
C26
|
A:61F301
|
1.7
|
78.0
|
0.3
|
C26
|
A:61F301
|
1.8
|
79.1
|
0.7
|
C28
|
A:61F301
|
2.7
|
73.6
|
0.3
|
C25
|
A:61F301
|
2.8
|
83.0
|
0.3
|
C28
|
A:61F301
|
2.8
|
74.3
|
0.7
|
C25
|
A:61F301
|
2.8
|
84.8
|
0.7
|
OD1
|
A:ASN74
|
3.1
|
43.7
|
1.0
|
N20
|
A:61F301
|
3.2
|
90.9
|
0.7
|
N20
|
A:61F301
|
3.3
|
90.0
|
0.3
|
C19
|
A:61F301
|
3.3
|
89.3
|
0.7
|
C19
|
A:61F301
|
3.4
|
88.9
|
0.3
|
CG
|
A:ASN74
|
3.6
|
37.5
|
1.0
|
ND2
|
A:ASN74
|
3.7
|
39.2
|
1.0
|
O
|
A:LYS70
|
3.7
|
33.0
|
1.0
|
CG2
|
A:ILE73
|
3.8
|
30.1
|
1.0
|
C29
|
A:61F301
|
4.0
|
74.1
|
0.3
|
O
|
A:HOH423
|
4.0
|
28.7
|
1.0
|
C11
|
A:61F301
|
4.0
|
81.6
|
0.3
|
C29
|
A:61F301
|
4.1
|
73.4
|
0.7
|
C11
|
A:61F301
|
4.1
|
83.1
|
0.7
|
CB
|
A:ILE73
|
4.1
|
31.3
|
1.0
|
CA
|
A:LYS70
|
4.3
|
36.4
|
1.0
|
CB
|
A:LYS70
|
4.3
|
39.7
|
1.0
|
C
|
A:LYS70
|
4.4
|
37.3
|
1.0
|
N
|
A:ASN74
|
4.4
|
31.8
|
1.0
|
C10
|
A:61F301
|
4.5
|
76.8
|
0.3
|
C10
|
A:61F301
|
4.6
|
76.4
|
0.7
|
N18
|
A:61F301
|
4.6
|
89.2
|
0.7
|
N18
|
A:61F301
|
4.7
|
87.8
|
0.3
|
CG
|
A:LYS70
|
4.7
|
51.2
|
1.0
|
CB
|
A:ASN74
|
4.7
|
34.1
|
1.0
|
S21
|
A:61F301
|
4.7
|
109.7
|
0.7
|
CE
|
A:LYS70
|
4.8
|
78.4
|
1.0
|
S21
|
A:61F301
|
4.8
|
109.0
|
0.3
|
CA
|
A:ASN74
|
4.8
|
32.6
|
1.0
|
C
|
A:ILE73
|
4.8
|
29.8
|
1.0
|
CG2
|
A:THR107
|
4.9
|
58.6
|
1.0
|
N12
|
A:61F301
|
5.0
|
83.3
|
0.3
|
N12
|
A:61F301
|
5.0
|
84.4
|
0.7
|
|
Chlorine binding site 2 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 2 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl301
b:77.2
occ:0.35
|
CL27
|
A:61F301
|
0.0
|
77.2
|
0.3
|
CL27
|
A:61F301
|
0.1
|
76.8
|
0.7
|
C26
|
A:61F301
|
1.8
|
78.0
|
0.3
|
C26
|
A:61F301
|
1.9
|
79.1
|
0.7
|
C28
|
A:61F301
|
2.8
|
73.6
|
0.3
|
C25
|
A:61F301
|
2.8
|
83.0
|
0.3
|
C25
|
A:61F301
|
2.8
|
84.8
|
0.7
|
C28
|
A:61F301
|
2.9
|
74.3
|
0.7
|
OD1
|
A:ASN74
|
3.0
|
43.7
|
1.0
|
N20
|
A:61F301
|
3.1
|
90.9
|
0.7
|
N20
|
A:61F301
|
3.2
|
90.0
|
0.3
|
C19
|
A:61F301
|
3.3
|
89.3
|
0.7
|
C19
|
A:61F301
|
3.3
|
88.9
|
0.3
|
CG
|
A:ASN74
|
3.5
|
37.5
|
1.0
|
ND2
|
A:ASN74
|
3.6
|
39.2
|
1.0
|
O
|
A:LYS70
|
3.7
|
33.0
|
1.0
|
CG2
|
A:ILE73
|
3.9
|
30.1
|
1.0
|
O
|
A:HOH423
|
4.0
|
28.7
|
1.0
|
C29
|
A:61F301
|
4.1
|
74.1
|
0.3
|
C11
|
A:61F301
|
4.1
|
81.6
|
0.3
|
C11
|
A:61F301
|
4.1
|
83.1
|
0.7
|
C29
|
A:61F301
|
4.2
|
73.4
|
0.7
|
CB
|
A:ILE73
|
4.2
|
31.3
|
1.0
|
CB
|
A:LYS70
|
4.3
|
39.7
|
1.0
|
CA
|
A:LYS70
|
4.3
|
36.4
|
1.0
|
C
|
A:LYS70
|
4.4
|
37.3
|
1.0
|
N
|
A:ASN74
|
4.4
|
31.8
|
1.0
|
C10
|
A:61F301
|
4.6
|
76.8
|
0.3
|
N18
|
A:61F301
|
4.6
|
89.2
|
0.7
|
N18
|
A:61F301
|
4.6
|
87.8
|
0.3
|
S21
|
A:61F301
|
4.6
|
109.7
|
0.7
|
CB
|
A:ASN74
|
4.6
|
34.1
|
1.0
|
C10
|
A:61F301
|
4.6
|
76.4
|
0.7
|
CG
|
A:LYS70
|
4.7
|
51.2
|
1.0
|
CE
|
A:LYS70
|
4.7
|
78.4
|
1.0
|
S21
|
A:61F301
|
4.7
|
109.0
|
0.3
|
CA
|
A:ASN74
|
4.8
|
32.6
|
1.0
|
C
|
A:ILE73
|
4.9
|
29.8
|
1.0
|
O24
|
A:61F301
|
4.9
|
105.4
|
0.7
|
N12
|
A:61F301
|
5.0
|
83.3
|
0.3
|
N12
|
A:61F301
|
5.0
|
84.4
|
0.7
|
CG2
|
A:THR107
|
5.0
|
58.6
|
1.0
|
O24
|
A:61F301
|
5.0
|
105.0
|
0.3
|
|
Chlorine binding site 3 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 3 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl303
b:19.9
occ:1.00
|
CD
|
A:GLN63
|
3.9
|
36.7
|
1.0
|
CG
|
A:GLN63
|
3.9
|
27.9
|
1.0
|
N
|
A:GLY61
|
4.1
|
36.3
|
1.0
|
NE2
|
A:GLN63
|
4.1
|
33.0
|
1.0
|
OE1
|
A:GLN63
|
4.3
|
35.7
|
1.0
|
CA
|
A:GLY60
|
4.7
|
43.6
|
1.0
|
CA
|
A:GLY61
|
4.8
|
34.1
|
1.0
|
O
|
A:VAL59
|
4.9
|
35.7
|
1.0
|
C
|
A:GLY60
|
5.0
|
44.7
|
1.0
|
|
Chlorine binding site 4 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 4 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl304
b:27.7
occ:1.00
|
O
|
A:GLY106
|
3.1
|
39.1
|
1.0
|
ND2
|
A:ASN53
|
3.5
|
42.0
|
1.0
|
CA
|
A:GLN50
|
3.6
|
27.5
|
1.0
|
CG
|
A:GLN50
|
3.9
|
35.5
|
1.0
|
CB
|
A:GLN50
|
3.9
|
29.2
|
1.0
|
C
|
A:GLY106
|
4.0
|
35.7
|
1.0
|
CA
|
A:GLY106
|
4.1
|
30.4
|
1.0
|
NE2
|
A:GLN114
|
4.1
|
25.7
|
1.0
|
C07
|
A:61F301
|
4.2
|
69.0
|
0.7
|
C07
|
A:61F301
|
4.2
|
66.9
|
0.3
|
N
|
A:GLN50
|
4.2
|
24.0
|
1.0
|
CG
|
A:ASN53
|
4.4
|
39.0
|
1.0
|
CB
|
A:ASN53
|
4.4
|
37.6
|
1.0
|
O
|
A:PRO49
|
4.6
|
24.4
|
1.0
|
C
|
A:PRO49
|
4.6
|
23.4
|
1.0
|
C60
|
A:61F301
|
4.7
|
58.5
|
0.3
|
C
|
A:GLN50
|
4.8
|
26.1
|
1.0
|
C06
|
A:61F301
|
4.8
|
66.7
|
0.3
|
C08
|
A:61F301
|
4.8
|
73.2
|
0.7
|
O
|
A:SER109
|
4.8
|
30.3
|
1.0
|
C05
|
A:61F301
|
4.8
|
66.5
|
0.3
|
C06
|
A:61F301
|
4.8
|
68.1
|
0.7
|
O
|
A:GLN50
|
4.9
|
25.0
|
1.0
|
C08
|
A:61F301
|
4.9
|
73.1
|
0.3
|
C05
|
A:61F301
|
4.9
|
68.9
|
0.7
|
|
Chlorine binding site 5 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 5 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl305
b:23.6
occ:1.00
|
NE2
|
A:GLN219
|
3.7
|
74.3
|
1.0
|
CE
|
A:MET215
|
3.7
|
41.6
|
1.0
|
CG
|
A:GLN219
|
4.0
|
72.2
|
1.0
|
CD
|
A:ARG162
|
4.0
|
40.2
|
1.0
|
CB
|
A:ARG162
|
4.2
|
38.1
|
1.0
|
O
|
A:HOH437
|
4.3
|
36.1
|
1.0
|
CD
|
A:GLN219
|
4.3
|
79.7
|
1.0
|
NH1
|
A:ARG162
|
4.3
|
59.0
|
1.0
|
NE
|
A:ARG162
|
4.4
|
54.7
|
1.0
|
O
|
A:MET215
|
4.4
|
41.4
|
1.0
|
CZ
|
A:ARG162
|
4.5
|
65.3
|
1.0
|
CB
|
A:MET215
|
4.5
|
32.1
|
1.0
|
CG
|
A:ARG162
|
4.6
|
40.4
|
1.0
|
C
|
A:MET215
|
4.9
|
45.5
|
1.0
|
|
Chlorine binding site 6 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 6 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl306
b:33.0
occ:1.00
|
CD
|
A:PRO17
|
3.8
|
27.8
|
1.0
|
N
|
A:ARG18
|
3.9
|
29.1
|
1.0
|
CB
|
A:ARG18
|
3.9
|
32.8
|
1.0
|
CB
|
A:SER16
|
4.1
|
27.0
|
1.0
|
N
|
A:PRO17
|
4.3
|
29.5
|
1.0
|
CG
|
A:PRO17
|
4.4
|
28.6
|
1.0
|
CA
|
A:ARG18
|
4.5
|
32.0
|
1.0
|
OG
|
A:SER16
|
4.6
|
29.8
|
1.0
|
CB
|
A:PRO17
|
4.6
|
30.5
|
1.0
|
C
|
A:PRO17
|
4.8
|
29.9
|
1.0
|
CA
|
A:PRO17
|
4.8
|
28.8
|
1.0
|
C
|
A:SER16
|
4.9
|
30.3
|
1.0
|
CA
|
A:SER16
|
4.9
|
26.9
|
1.0
|
|
Chlorine binding site 7 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 7 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 7 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl307
b:27.3
occ:1.00
|
CB
|
A:ALA22
|
4.6
|
22.3
|
1.0
|
O
|
A:ARG18
|
4.9
|
29.1
|
1.0
|
|
Chlorine binding site 8 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 8 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 8 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl301
b:50.1
occ:0.59
|
CL27
|
B:61F301
|
0.0
|
50.1
|
0.6
|
CL27
|
B:61F301
|
0.1
|
49.6
|
0.4
|
C26
|
B:61F301
|
1.7
|
46.5
|
0.4
|
C26
|
B:61F301
|
1.8
|
46.5
|
0.6
|
C25
|
B:61F301
|
2.7
|
49.9
|
0.4
|
C28
|
B:61F301
|
2.7
|
42.0
|
0.4
|
C28
|
B:61F301
|
2.8
|
42.0
|
0.6
|
C25
|
B:61F301
|
2.8
|
49.9
|
0.6
|
OD1
|
B:ASN74
|
3.0
|
39.9
|
1.0
|
N20
|
B:61F301
|
3.1
|
50.6
|
0.4
|
N20
|
B:61F301
|
3.1
|
50.6
|
0.6
|
C19
|
B:61F301
|
3.2
|
51.0
|
0.4
|
C19
|
B:61F301
|
3.3
|
51.0
|
0.6
|
O
|
B:HOH422
|
3.5
|
38.6
|
1.0
|
CG2
|
B:ILE73
|
3.5
|
25.2
|
1.0
|
CG
|
B:ASN74
|
3.6
|
36.6
|
1.0
|
O
|
B:LYS70
|
3.8
|
31.2
|
1.0
|
ND2
|
B:ASN74
|
3.8
|
37.2
|
1.0
|
C11
|
B:61F301
|
3.9
|
49.6
|
0.4
|
C29
|
B:61F301
|
4.0
|
42.7
|
0.4
|
CB
|
B:ILE73
|
4.0
|
26.2
|
1.0
|
C29
|
B:61F301
|
4.1
|
42.7
|
0.6
|
C11
|
B:61F301
|
4.1
|
49.7
|
0.6
|
N
|
B:ASN74
|
4.3
|
29.8
|
1.0
|
C10
|
B:61F301
|
4.5
|
45.2
|
0.4
|
CA
|
B:LYS70
|
4.5
|
30.7
|
1.0
|
N18
|
B:61F301
|
4.5
|
52.5
|
0.4
|
C
|
B:LYS70
|
4.5
|
29.4
|
1.0
|
C10
|
B:61F301
|
4.6
|
45.2
|
0.6
|
N18
|
B:61F301
|
4.6
|
52.5
|
0.6
|
CB
|
B:LYS70
|
4.6
|
33.7
|
1.0
|
S21
|
B:61F301
|
4.6
|
55.4
|
0.4
|
C
|
B:ILE73
|
4.6
|
29.2
|
1.0
|
S21
|
B:61F301
|
4.7
|
55.3
|
0.6
|
CB
|
B:ALA105
|
4.7
|
24.9
|
1.0
|
CB
|
B:ASN74
|
4.7
|
35.6
|
1.0
|
CA
|
B:ASN74
|
4.7
|
34.3
|
1.0
|
CG2
|
B:THR107
|
4.8
|
43.1
|
1.0
|
N12
|
B:61F301
|
4.8
|
50.3
|
0.4
|
O24
|
B:61F301
|
4.9
|
58.9
|
0.4
|
CA
|
B:ILE73
|
4.9
|
29.3
|
1.0
|
CD1
|
B:ILE73
|
4.9
|
22.4
|
1.0
|
O24
|
B:61F301
|
4.9
|
59.5
|
0.6
|
N12
|
B:61F301
|
5.0
|
50.2
|
0.6
|
CG
|
B:LYS70
|
5.0
|
39.6
|
1.0
|
|
Chlorine binding site 9 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 9 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 9 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl301
b:49.6
occ:0.41
|
CL27
|
B:61F301
|
0.0
|
49.6
|
0.4
|
CL27
|
B:61F301
|
0.1
|
50.1
|
0.6
|
C26
|
B:61F301
|
1.8
|
46.5
|
0.4
|
C26
|
B:61F301
|
1.9
|
46.5
|
0.6
|
C28
|
B:61F301
|
2.8
|
42.0
|
0.4
|
C25
|
B:61F301
|
2.8
|
49.9
|
0.4
|
C28
|
B:61F301
|
2.9
|
42.0
|
0.6
|
C25
|
B:61F301
|
2.9
|
49.9
|
0.6
|
OD1
|
B:ASN74
|
3.0
|
39.9
|
1.0
|
N20
|
B:61F301
|
3.1
|
50.6
|
0.4
|
N20
|
B:61F301
|
3.2
|
50.6
|
0.6
|
C19
|
B:61F301
|
3.3
|
51.0
|
0.4
|
C19
|
B:61F301
|
3.4
|
51.0
|
0.6
|
CG2
|
B:ILE73
|
3.4
|
25.2
|
1.0
|
CG
|
B:ASN74
|
3.5
|
36.6
|
1.0
|
O
|
B:HOH422
|
3.6
|
38.6
|
1.0
|
O
|
B:LYS70
|
3.6
|
31.2
|
1.0
|
ND2
|
B:ASN74
|
3.8
|
37.2
|
1.0
|
CB
|
B:ILE73
|
3.8
|
26.2
|
1.0
|
C29
|
B:61F301
|
4.1
|
42.7
|
0.4
|
C11
|
B:61F301
|
4.1
|
49.6
|
0.4
|
C29
|
B:61F301
|
4.2
|
42.7
|
0.6
|
N
|
B:ASN74
|
4.2
|
29.8
|
1.0
|
C11
|
B:61F301
|
4.2
|
49.7
|
0.6
|
CA
|
B:LYS70
|
4.4
|
30.7
|
1.0
|
C
|
B:LYS70
|
4.4
|
29.4
|
1.0
|
C
|
B:ILE73
|
4.5
|
29.2
|
1.0
|
CB
|
B:LYS70
|
4.5
|
33.7
|
1.0
|
C10
|
B:61F301
|
4.6
|
45.2
|
0.4
|
CB
|
B:ASN74
|
4.6
|
35.6
|
1.0
|
N18
|
B:61F301
|
4.6
|
52.5
|
0.4
|
CA
|
B:ASN74
|
4.6
|
34.3
|
1.0
|
S21
|
B:61F301
|
4.7
|
55.4
|
0.4
|
S21
|
B:61F301
|
4.7
|
55.3
|
0.6
|
C10
|
B:61F301
|
4.7
|
45.2
|
0.6
|
N18
|
B:61F301
|
4.7
|
52.5
|
0.6
|
CB
|
B:ALA105
|
4.8
|
24.9
|
1.0
|
CA
|
B:ILE73
|
4.8
|
29.3
|
1.0
|
CD1
|
B:ILE73
|
4.8
|
22.4
|
1.0
|
O24
|
B:61F301
|
4.9
|
58.9
|
0.4
|
CG
|
B:LYS70
|
4.9
|
39.6
|
1.0
|
O24
|
B:61F301
|
4.9
|
59.5
|
0.6
|
CG2
|
B:THR107
|
4.9
|
43.1
|
1.0
|
CG1
|
B:ILE73
|
5.0
|
26.5
|
1.0
|
N12
|
B:61F301
|
5.0
|
50.3
|
0.4
|
|
Chlorine binding site 10 out
of 23 in 7rmj
Go back to
Chlorine Binding Sites List in 7rmj
Chlorine binding site 10 out
of 23 in the Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 10 of Disulfide Stabilized Hiv-1 Ca Hexamer in Complex with Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)- 1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin- 2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7- Tetrahydro-1H-Indazol-1-Yl)Acetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl304
b:36.8
occ:1.00
|
O
|
B:GLY106
|
3.0
|
33.7
|
1.0
|
O
|
B:HOH448
|
3.1
|
37.4
|
1.0
|
ND2
|
B:ASN53
|
3.4
|
33.0
|
1.0
|
CA
|
B:GLN50
|
3.6
|
24.4
|
1.0
|
CB
|
B:GLN50
|
3.8
|
23.4
|
1.0
|
CG
|
B:GLN50
|
3.9
|
25.4
|
1.0
|
C
|
B:GLY106
|
3.9
|
32.0
|
1.0
|
C07
|
B:61F301
|
4.0
|
43.2
|
0.6
|
CA
|
B:GLY106
|
4.1
|
27.6
|
1.0
|
N
|
B:GLN50
|
4.1
|
21.8
|
1.0
|
NE2
|
B:GLN114
|
4.2
|
24.4
|
1.0
|
C07
|
B:61F301
|
4.2
|
43.1
|
0.4
|
CG
|
B:ASN53
|
4.3
|
28.5
|
1.0
|
CB
|
B:ASN53
|
4.4
|
27.3
|
1.0
|
O
|
B:PRO49
|
4.5
|
21.0
|
1.0
|
C
|
B:PRO49
|
4.6
|
24.4
|
1.0
|
C08
|
B:61F301
|
4.6
|
43.4
|
0.6
|
C
|
B:GLN50
|
4.8
|
25.8
|
1.0
|
C60
|
B:61F301
|
4.8
|
33.8
|
0.4
|
C08
|
B:61F301
|
4.8
|
43.4
|
0.4
|
C06
|
B:61F301
|
4.8
|
41.4
|
0.6
|
O
|
B:GLN50
|
4.9
|
21.6
|
1.0
|
O
|
B:SER109
|
4.9
|
26.3
|
1.0
|
C06
|
B:61F301
|
4.9
|
41.5
|
0.4
|
CD
|
B:GLN50
|
5.0
|
35.6
|
1.0
|
C05
|
B:61F301
|
5.0
|
41.0
|
0.6
|
|
Reference:
S.M.Bester,
D.Adu-Ampratwum,
A.S.Annamalai,
G.Wei,
L.Briganti,
B.C.Murphy,
R.Haney,
J.R.Fuchs,
M.Kvaratskhelia.
Structural and Mechanistic Bases of Viral Resistance to Hiv-1 Capsid Inhibitor Lenacapavir. Mbio V. 13 80422 2022.
ISSN: ESSN 2150-7511
PubMed: 36190128
DOI: 10.1128/MBIO.01804-22
Page generated: Tue Jul 30 03:44:42 2024
|